High-dose (HDS) chemotherapy in multiple myeloma: Residual tumor cells are detectable in PBPC and BM cell harvests and after single or double autografting.

被引：0
|
作者：
Corradini, P [1 ]
Astolfi, M [1 ]
Ladetto, M [1 ]
Campana, S [1 ]
Comoglio, F [1 ]
Tarella, C [1 ]
Boccadoro, M [1 ]
Pileri, A [1 ]
机构：
[1] UNIV TURIN,AZ OSPED S GIOVANNI BATTISTA,DIP MED & ONCOL SPERIMENTALE,DIV EMATOL,TURIN,ITALY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：810 / 810
页数：1
相关论文
共 50 条
  • [41] Infectious complications after high-dose chemotherapy and autologous stem cell transplantation:: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors
    Reich, G
    Mapara, MY
    Reichardt, P
    Dörken, B
    Maschmeyer, G
    BONE MARROW TRANSPLANTATION, 2001, 27 (05) : 525 - 529
  • [42] Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
    Inamoto, Y.
    Kurahashi, S.
    Fukushima, N.
    Imahashi, N.
    Murata, M.
    Tsushita, K.
    Miyamura, K.
    Kinoshita, T.
    Naoe, T.
    Kodera, Y.
    Sugiura, I.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S182 - S182
  • [43] Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
    Inamoto, Yoshihiro
    Kurahashi, Shingo
    Imahashi, Nobuhiko
    Fukushima, Nobuaki
    Adachi, Tatsuya
    Kinoshita, Tomohiro
    Tsushita, Keitaro
    Miyamura, Koichi
    Naoe, Tomoki
    Sugiura, Isamu
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) : 283 - 286
  • [44] Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
    Shamchi, Sara Pourhassan
    Zadeh, Mahdi Zirakchian
    Ostergaard, Brian
    Kim, Jennifer
    Raynor, William Y.
    Khosravi, Mohsen
    Taghvaei, Raheleh
    Nielsen, Anne L.
    Gerke, Oke
    Werner, Thomas J.
    Holdgaard, Paw
    Abildgaard, Niels
    Revheim, Mona-Elisabeth
    Hoilund-Carlsen, Poul Flemming
    Alavi, Abass
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (03) : 288 - 293
  • [45] Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study
    Trudel, S
    Li, Z
    Dodgson, C
    Nanji, S
    Wan, Y
    Voralia, M
    Hitt, M
    Gauldie, J
    Graham, FL
    Stewart, AK
    LEUKEMIA, 2001, 15 (05) : 846 - 854
  • [46] Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation
    Soverini, S
    Cavo, M
    Cellini, C
    Terragna, C
    Zamagni, E
    Ruggeri, D
    Testoni, N
    Tosi, P
    de Vivo, A
    Amabile, M
    Grafone, T
    Ottaviani, E
    Giannini, B
    Cangini, D
    Bonifazi, F
    Neri, A
    Fabris, S
    Tura, S
    Baccarani, M
    Martinelli, G
    BLOOD, 2003, 102 (05) : 1588 - 1594
  • [47] HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HAEMATOPOETIC STEM CELL TRANSPLANTATION AS FRONT LINE THERAPY IN MULTIPLE MYELOMA IN THE NOVEL AGENTS ERA: A SINGLE CENTRE EXPERIENCE
    Nozzoli, C.
    Veltroni, A.
    Staderini, M.
    Bacchiarri, F.
    Guidi, S.
    Longo, G.
    Gozzini, A.
    Donnini, I.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S453 - S453
  • [48] Treatment of patients with multiple myeloma in first relapse after high-dose chemotherapy with single agent thalidomide - duration of first remission is the major prognostic factor for EFS and OS
    Hoyer, B
    Fenk, R
    Steidl, U
    Germing, U
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S162 - S162
  • [49] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA. A SINGLE CENTER EXPERIENCE FROM EHU1ST NOVEMBER OF ORAN.
    Bekadja, A.
    Osmani, S.
    Talhi, S.
    Yafour, N.
    Brahimi, M.
    Arabi, A.
    Bouhass, R.
    HAEMATOLOGICA, 2013, 98 : 611 - 611
  • [50] Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation
    Lipinski, E
    Cremer, FW
    Ho, AD
    Goldschmidt, H
    Moos, M
    BONE MARROW TRANSPLANTATION, 2001, 28 (10) : 957 - 962
12345